These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 18648137

  • 1. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM, Simons BW, Prosser BJ, Ruben DS, Giday SA, Magno P, Clarke JO, Shin EJ, Kalloo AN, Kantsevoy SV, Gabrielson KL, Jagannath SB.
    JOP; 2008 Jul 10; 9(4):456-67. PubMed ID: 18648137
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. What are the predictors of post-ERCP pancreatitis, and how useful are they?
    Sultan S, Baillie J.
    JOP; 2002 Nov 10; 3(6):188-94. PubMed ID: 12432185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model.
    Pfau PR, Mosley RG, Said A, Gopal DV, Fischer MC, Oberley T, Weiss J, Lee FT, Eckoff D, Reichelderfer M.
    JOP; 2006 Jan 11; 7(1):27-33. PubMed ID: 16407615
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS, Wu SM, Wang ZH, Mo JZ, Xiao SD.
    J Gastroenterol Hepatol; 2007 Mar 11; 22(3):371-6. PubMed ID: 17295769
    [Abstract] [Full Text] [Related]

  • 10. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
    Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Centorrino T, Siriwardena AK, Cuzzocrea S.
    Shock; 2007 May 11; 27(5):542-51. PubMed ID: 17438460
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA.
    Am J Gastroenterol; 2006 Jan 11; 101(1):139-47. PubMed ID: 16405547
    [Abstract] [Full Text] [Related]

  • 12. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
    Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman GA.
    Am J Gastroenterol; 1996 Aug 11; 91(8):1553-7. PubMed ID: 8759660
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
    Kapetanos D, Kokozidis G, Christodoulou D, Mistakidis K, Sigounas D, Dimakopoulos K, Kitis G, Tsianos EV.
    Gastrointest Endosc; 2007 Sep 11; 66(3):513-8. PubMed ID: 17725940
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes.
    Doppl WE, Weber HP, Temme H, Klör HU, Federlin K.
    Eur J Med Res; 1996 Mar 19; 1(6):303-11. PubMed ID: 9367944
    [Abstract] [Full Text] [Related]

  • 15. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V.
    N Engl J Med; 1996 Sep 26; 335(13):919-23. PubMed ID: 8786777
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L, Kurucsai G, Fejes R, Székely A, Székely I.
    Dig Endosc; 2009 Jan 26; 21(1):8-13. PubMed ID: 19691794
    [Abstract] [Full Text] [Related]

  • 17. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW, Kang DH, Kim GH, Eum JS, Lee SM, Song GA, Kim DU, Kim ID, Cho M.
    Gastrointest Endosc; 2009 Apr 26; 69(4):e11-8. PubMed ID: 19327467
    [Abstract] [Full Text] [Related]

  • 18. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
    Conn M, Goldenberg A, Concepcion L, Mandeli J.
    Am J Gastroenterol; 1991 Aug 26; 86(8):1011-4. PubMed ID: 1713406
    [Abstract] [Full Text] [Related]

  • 19. Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis.
    Kemppainen E, Hedström J, Puolakkainen P, Halttunen J, Sainio V, Haapiainen R, Stenman UH.
    Endoscopy; 1997 May 26; 29(4):247-51. PubMed ID: 9255526
    [Abstract] [Full Text] [Related]

  • 20. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA.
    JOP; 2003 Jan 26; 4(1):22-32. PubMed ID: 12555013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.